VIRP.PA
Price:
$354
Market Cap:
$2.94B
Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.[Read more]
Industry
Drug Manufacturers - General
IPO Date
1992-07-07
Stock Exchange
EURONEXT
Ticker
VIRP.PA
According to Virbac SA’s latest financial reports and current stock price. The company's current Current Ratio is 1.65. This represents a change of -12.88% compared to the average of 1.90 of the last 4 quarters.
The mean historical Current Ratio of Virbac SA over the last ten years is 1.47. The current 1.65 Current Ratio has changed 11.12% with respect to the historical average. Over the past ten years (40 quarters), VIRP.PA's Current Ratio was at its highest in in the June 2020 quarter at 2.28. The Current Ratio was at its lowest in in the January 2009 quarter at 0.
Average
1.47
Median
1.34
Minimum
1.10
Maximum
1.93
Discovering the peaks and valleys of Virbac SA Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 51.02%
Maximum Annual Current Ratio = 1.93
Minimum Annual Increase = -17.30%
Minimum Annual Current Ratio = 1.10
Year | Current Ratio | Change |
---|---|---|
2023 | 1.93 | 4.37% |
2022 | 1.85 | 9.94% |
2021 | 1.68 | -7.83% |
2020 | 1.83 | 51.02% |
2019 | 1.21 | -1.61% |
2018 | 1.23 | 0.89% |
2017 | 1.22 | 10.58% |
2016 | 1.10 | -17.30% |
2015 | 1.33 | -0.95% |
2014 | 1.35 | -6.10% |
The current Current Ratio of Virbac SA (VIRP.PA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
1.82
5-year avg
1.70
10-year avg
1.47
Virbac SA’s Current Ratio is less than Vetoquinol SA (2.76), less than Trigano S.A. (1.97), less than bioMérieux S.A. (2.21), less than Sartorius Stedim Biotech S.A. (2.14), greater than Ipsen S.A. (1.14),
Company | Current Ratio | Market cap |
---|---|---|
2.76 | $931.15M | |
1.97 | $2.41B | |
2.21 | $12.15B | |
2.14 | $18.27B | |
1.14 | $9.28B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Virbac SA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Virbac SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Virbac SA's Current Ratio?
How is the Current Ratio calculated for Virbac SA (VIRP.PA)?
What is the highest Current Ratio for Virbac SA (VIRP.PA)?
What is the 3-year average Current Ratio for Virbac SA (VIRP.PA)?
What is the 5-year average Current Ratio for Virbac SA (VIRP.PA)?
How does the current Current Ratio for Virbac SA (VIRP.PA) compare to its historical average?